FWIA
VIVO

Fort Washington Investment Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Fort Washington Investment Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-609,314
Closed -$19.2M – 421
2022
Q3 		$19.2M Sell
609,314
-31,104
-5% -$1.01M 0.16% 132
2022
Q2 		$19.5M Hold
640,418
– – 0.15% 135
2022
Q1 		$16.6M Buy
640,418
+197,550
+45% +$4.7M 0.11% 144
2021
Q4 		$9.04M Hold
442,868
– – 0.05% 212
2021
Q3 		$8.52M Hold
442,868
– – 0.05% 218
2021
Q2 		$9.82M Buy
+442,868
New +$9.39M 0.09% 206

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fort Washington Investment Advisors's VIVO Position: Q4 2022 in Review

Fort Washington Investment Advisors sold out of Meridian Bioscience Inc (VIVO) in Q4 2022, closing a stake of 609,314 shares — an estimated $19.2M sold.

Fort Washington Investment Advisors first reported a position in VIVO in Q2 2021 and held it in 6 quarters. The position peaked at $19.5M in Q2 2022. 218 funds tracked by Wall St. Rank hold VIVO as of Q4 2022.

  • Fort Washington Investment Advisors reported no remaining Meridian Bioscience Inc position as of Q4 2022 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 609,314 Meridian Bioscience Inc shares in Q4 2022, an estimated $19.2M.
  • Fort Washington Investment Advisors first reported a position in Meridian Bioscience Inc in Q2 2021 and held it in 6 quarters.
  • Fort Washington Investment Advisors's Meridian Bioscience Inc position peaked at $19.5M in Q2 2022.
  • 218 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2022.

Based on Fort Washington Investment Advisors's 13F filing for Q4 2022, filed 30 Jan 2023.